Waiting for the next wave - how Medtronic plans to get back on track
This article was originally published in Clinica
Executive Summary
Medtronic told stockholders last week that despite recent disappointing earnings, it is poised for a period of rapid growth resulting from an impressive array of new technologies and therapies. Karen Riley reports.